Gold prices steady ahead of Fed decision; weekly weakness noted
Investing.com - Minerva Neurosciences reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Minerva Neurosciences announced earnings per share of $-1.290 on revenue of $0.00. Analysts polled by Investing.com EPS of $-1.380 on revenue of $0.
Minerva Neurosciences 's are down 28.9% and is trading at $3.173 , still down 79.22% from its 52 week high of $15.27 set on Wednesday, August 31, 2022.
Minerva Neurosciences shares gained 5.94% to trade at $3.173 in intra-day trade the report.
Minerva Neurosciences follows other major Healthcare sector earnings this month
Minerva Neurosciences's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar